Praise for INSIDE THE FDA "A clear-eyed, thoughtful look at an agency that regulates a quarter of the U.S. economy and, more than any other, has the safety of the American public in its hands. Inside the FDA makes plain how powerful and controversial the Food and Drug Administration has become. People seeking to understand the government's role in health care and the biotech revolution would be wise to read Ms. Hawthorne's book." --Elizabeth MacBride Health-care writer and former managing editor of Crain's New York Business > --Clem Morgello Former senior editor and columnist at Newsweek, and…mehr
Praise for INSIDE THE FDA "A clear-eyed, thoughtful look at an agency that regulates a quarter of the U.S. economy and, more than any other, has the safety of the American public in its hands. Inside the FDA makes plain how powerful and controversial the Food and Drug Administration has become. People seeking to understand the government's role in health care and the biotech revolution would be wise to read Ms. Hawthorne's book." --Elizabeth MacBride Health-care writer and former managing editor of Crain's New York Business > --Clem Morgello Former senior editor and columnist at Newsweek, and former senior editor at Dun's Review Praise for THE MERCK DRUGGERNAUT > --The New York Times
FRAN HAWTHORNE is Senior Contributing Editor of Institutional Investor and has connections deep within the business and finance communities. Hawthorne has been covering health care and business for more than twenty years for Fortune, Crain's New York Business, and other publications, and she now writes regularly for such newspapers and magazines as the New York Times, Worth, and Self. She is the author of The Merck Druggernaut, which is also published by Wiley.
Inhaltsangabe
Introduction v Chapter 1: Case Study: Chasing Cancer 1 Chapter 2: Beyond Science 23 Chapter 3: The First 100 Years 35 Chapter 4: "You Don't Know Which Agency Is in Charge" 65 Chapter 5: Truckloads of Paper 79 Chapter 6: Case Study: The Return of Thalidomide 109 Chapter 7: How Picky Is the FDA? 123 Chapter 8: How Powerful Is Industry? 143 Chapter 9: Case Study: The Death of Monica George 179 Chapter 10: When Consumers Get Angry 191 Chapter 11: A Political Pawn 209 Chapter 12: FDA and DNA 233 Chapter 13: The FDA Meets Madison Avenue 253 Chapter 14: Frivolous Drugs? 273 Chapter 15: The Next 100 Years 285 Acknowledgments 309 Notes 311 Bibliography 329 Index 333
Introduction v Chapter 1: Case Study: Chasing Cancer 1 Chapter 2: Beyond Science 23 Chapter 3: The First 100 Years 35 Chapter 4: "You Don't Know Which Agency Is in Charge" 65 Chapter 5: Truckloads of Paper 79 Chapter 6: Case Study: The Return of Thalidomide 109 Chapter 7: How Picky Is the FDA? 123 Chapter 8: How Powerful Is Industry? 143 Chapter 9: Case Study: The Death of Monica George 179 Chapter 10: When Consumers Get Angry 191 Chapter 11: A Political Pawn 209 Chapter 12: FDA and DNA 233 Chapter 13: The FDA Meets Madison Avenue 253 Chapter 14: Frivolous Drugs? 273 Chapter 15: The Next 100 Years 285 Acknowledgments 309 Notes 311 Bibliography 329 Index 333
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826